11-1243512-G-C

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_002458.3(MUC5B):​c.6632G>C​(p.Arg2211Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.462 in 1,433,604 control chromosomes in the GnomAD database, including 176,584 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R2211C) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.38 ( 9470 hom., cov: 20)
Exomes 𝑓: 0.47 ( 167114 hom. )

Consequence

MUC5B
NM_002458.3 missense

Scores

17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.670

Publications

19 publications found
Variant links:
Genes affected
MUC5B (HGNC:7516): (mucin 5B, oligomeric mucus/gel-forming) This gene encodes a member of the mucin family of proteins, which are highly glycosylated macromolecular components of mucus secretions. This family member is the major gel-forming mucin in mucus. It is a major contributor to the lubricating and viscoelastic properties of whole saliva, normal lung mucus and cervical mucus. This gene has been found to be up-regulated in some human diseases, including sinus mucosa of chronic rhinosinusitis (CRS), CRS with nasal polyposis, chronic obstructive pulmonary disease (COPD) and H. pylori-associated gastric disease, and it may be involved in the pathogenesis of these diseases. [provided by RefSeq, Jul 2010]
MUC5B-AS1 (HGNC:53936): (MUC5B antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=4.529953E-4).
BP6
Variant 11-1243512-G-C is Benign according to our data. Variant chr11-1243512-G-C is described in ClinVar as Benign. ClinVar VariationId is 403139.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Homozygotes in GnomAd4 at 9470 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MUC5BNM_002458.3 linkc.6632G>C p.Arg2211Pro missense_variant Exon 31 of 49 ENST00000529681.5 NP_002449.2 Q9HC84
MUC5B-AS1NR_157183.1 linkn.57-874C>G intron_variant Intron 1 of 1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MUC5BENST00000529681.5 linkc.6632G>C p.Arg2211Pro missense_variant Exon 31 of 49 5 NM_002458.3 ENSP00000436812.1 Q9HC84
MUC5B-AS1ENST00000532061.2 linkn.57-874C>G intron_variant Intron 1 of 1 5

Frequencies

GnomAD3 genomes
AF:
0.375
AC:
43160
AN:
115034
Hom.:
9453
Cov.:
20
show subpopulations
Gnomad AFR
AF:
0.264
Gnomad AMI
AF:
0.472
Gnomad AMR
AF:
0.487
Gnomad ASJ
AF:
0.391
Gnomad EAS
AF:
0.553
Gnomad SAS
AF:
0.351
Gnomad FIN
AF:
0.506
Gnomad MID
AF:
0.348
Gnomad NFE
AF:
0.390
Gnomad OTH
AF:
0.377
GnomAD2 exomes
AF:
0.409
AC:
88330
AN:
216070
AF XY:
0.405
show subpopulations
Gnomad AFR exome
AF:
0.277
Gnomad AMR exome
AF:
0.460
Gnomad ASJ exome
AF:
0.365
Gnomad EAS exome
AF:
0.634
Gnomad FIN exome
AF:
0.421
Gnomad NFE exome
AF:
0.387
Gnomad OTH exome
AF:
0.405
GnomAD4 exome
AF:
0.469
AC:
618418
AN:
1318450
Hom.:
167114
Cov.:
116
AF XY:
0.466
AC XY:
306146
AN XY:
656660
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.319
AC:
10174
AN:
31872
American (AMR)
AF:
0.589
AC:
25643
AN:
43512
Ashkenazi Jewish (ASJ)
AF:
0.440
AC:
10655
AN:
24200
East Asian (EAS)
AF:
0.709
AC:
27459
AN:
38724
South Asian (SAS)
AF:
0.427
AC:
34645
AN:
81080
European-Finnish (FIN)
AF:
0.551
AC:
26445
AN:
48012
Middle Eastern (MID)
AF:
0.422
AC:
1657
AN:
3924
European-Non Finnish (NFE)
AF:
0.460
AC:
456260
AN:
991944
Other (OTH)
AF:
0.462
AC:
25480
AN:
55182
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.328
Heterozygous variant carriers
0
18422
36843
55265
73686
92108
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
12926
25852
38778
51704
64630
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.375
AC:
43209
AN:
115154
Hom.:
9470
Cov.:
20
AF XY:
0.383
AC XY:
21317
AN XY:
55708
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.264
AC:
8678
AN:
32858
American (AMR)
AF:
0.487
AC:
5782
AN:
11870
Ashkenazi Jewish (ASJ)
AF:
0.391
AC:
1039
AN:
2660
East Asian (EAS)
AF:
0.553
AC:
1619
AN:
2928
South Asian (SAS)
AF:
0.351
AC:
1213
AN:
3460
European-Finnish (FIN)
AF:
0.506
AC:
3838
AN:
7580
Middle Eastern (MID)
AF:
0.333
AC:
86
AN:
258
European-Non Finnish (NFE)
AF:
0.391
AC:
20041
AN:
51320
Other (OTH)
AF:
0.385
AC:
594
AN:
1544
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.384
Heterozygous variant carriers
0
910
1819
2729
3638
4548
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
380
760
1140
1520
1900
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.311
Hom.:
1010
ExAC
AF:
0.408
AC:
49352

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.062
BayesDel_addAF
Benign
-0.78
T
BayesDel_noAF
Benign
-0.75
CADD
Benign
4.0
DANN
Benign
0.50
DEOGEN2
Benign
0.015
T
Eigen
Benign
-1.5
Eigen_PC
Benign
-1.5
FATHMM_MKL
Benign
0.00017
N
LIST_S2
Benign
0.36
T
MetaRNN
Benign
0.00045
T
MetaSVM
Benign
-0.98
T
MutationAssessor
Benign
-0.81
N
PhyloP100
-0.67
PrimateAI
Benign
0.23
T
PROVEAN
Benign
0.61
N
REVEL
Benign
0.047
Sift
Benign
0.17
T
Vest4
0.023
ClinPred
0.00058
T
GERP RS
1.8
Varity_R
0.099
gMVP
0.28
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs137973688; hg19: chr11-1264742; COSMIC: COSV71589895; COSMIC: COSV71589895; API